Further Delineation of Duplications of ARX Locus Detected in Male Patients with Varying Degrees of Intellectual Disability
- Autori: Poeta L.; Malacarne M.; Padula A.; Drongitis D.; Verrillo L.; Lioi M.B.; Chiariello A.M.; Bianco S.; Nicodemi M.; Piccione M.; Salzano E.; Coviello D.; Miano M.G.
- Anno di pubblicazione: 2022
- Tipologia: Articolo in rivista
- Parole Chiave: 3D structure; ARX; Intellectual disability; KDM5C-SYN1 axis; Ultraconserved enhancers; Xp21.3 duplication; Animals; Child; Homeodomain Proteins; Humans; Male; Mice; Mutation; Transcription Factors; Genes, Homeobox; Intellectual Disability
- OA Link: http://hdl.handle.net/10447/547090
Abstract
The X-linked gene encoding aristaless-related homeobox (ARX) is a bi-functional transcription factor capable of activating or repressing gene transcription, whose mutations have been found in a wide spectrum of neurodevelopmental disorders (NDDs); these include cortical malformations, pae-diatric epilepsy, intellectual disability (ID) and autism. In addition to point mutations, duplications of the ARX locus have been detected in male patients with ID. These rearrangements include telen-cephalon ultraconserved enhancers, whose structural alterations can interfere with the control of ARX expression in the developing brain. Here, we review the structural features of 15 gain copy-number variants (CNVs) of the ARX locus found in patients presenting wide-ranging phenotypic variations including ID, speech delay, hypotonia and psychiatric abnormalities. We also report on a further novel Xp21.3 duplication detected in a male patient with moderate ID and carrying a fully duplicated copy of the ARX locus and the ultraconserved enhancers. As consequences of this rearrangement, the patient-derived lymphoblastoid cell line shows abnormal activity of the ARX-KDM5C-SYN1 regulatory axis. Moreover, the three-dimensional (3D) structure of the Arx locus, both in mouse embryonic stem cells and cortical neurons, provides new insight for the functional consequences of ARX duplications. Finally, by comparing the clinical features of the 16 CNVs affecting the ARX locus, we conclude that—depending on the involvement of tissue-specific enhancers—the ARX duplications are ID-associated risk CNVs with variable expressivity and penetrance.